2003 New Ventures BC 2nd prize winner Genologics quietly completed their 3rd round round of financing late last month adding another $5 million which will be applied towards ongoing expansion plans. This latest round of financing was led by OVP Venture Partners of Seattle with support from Growthworks and Yaletown Venture Partners of Vancouver.

Since 2005, the privately-held Victoria headquartered GenoLogics has attracted more than $17.5 million in investment from leading venture capital funds and strategic partners.

GenoLogics’ major investors include OVP Venture Partners, Yaletown Venture Partners, Growthworks Capital, and Tech veteran Don Listwin.  GenoLogics also benefits from the involvement of several of North America’s most accomplished life science and technology executives as angel investors.

2003 2nd place winner Genologics announced that they have signed a global agreement with Pfizer.

Thanks to the Vancouver Island Tech Park for the full details:

Under the terms of the agreement, GenoLogics will provide an enterprise enabled lab and data management system to capture, contextualize and integrate science data in multiple locations world wide. In addition to the ability to leverage data standards across labs by virtue of a common informatics platform, GenoLogics will provide Pfizer with the tools to enable web-based collaboration, bioinformatics pipelining, auditability and reporting of cross-science data.

Congratulations to Genologics!